EyePoint (EYPT) Inventory Average (2019 - 2026)
EyePoint (EYPT) posted Inventory Average of $1.5 million for Q1 2026, down 21.92% sequentially from $2.0 million in Q4 2025, and down 30.92% YoY from $2.2 million in Q1 2025.
EyePoint (EYPT) Inventory Average (2019 - 2026) Analysis & Trends
EyePoint has reported Inventory Average for 8 years, with the latest figure at $1.5 million in Q1 2026.
- Quarterly Inventory Average fell 30.92% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 30.92% YoY) and the FY2025 annual result came in at $2.1 million, down 33.7% from the prior year.
- Inventory Average slipped to $1.5 million in Q1 2026 per EYPT's latest filing, from $2.0 million in the prior quarter.
- Over five years, Inventory Average peaked at $4.4 million in Q3 2023 and troughed at $1.5 million in Q1 2026.
- A 5-year average of $3.2 million and a median of $3.3 million in 2022 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2025: Inventory Average surged 32.2% in 2023, then tumbled 45.68% in 2025.
- Over 5 years, Inventory Average stood at $3.2 million in 2022, then soared by 32.2% to $4.2 million in 2023, then slumped by 39.74% to $2.6 million in 2024, then retreated by 23.26% to $2.0 million in 2025, then retreated by 21.92% to $1.5 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $1.5 million, $2.0 million, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 4.08 Mn |
| Dec 31, 2023 | 4.24 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Jun 30, 2023 | 4.17 Mn |
| Mar 31, 2023 | 3.48 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 3.39 Mn |
| Jun 30, 2022 | 3.30 Mn |
| Mar 31, 2022 | 3.48 Mn |
| Dec 31, 2021 | 4.09 Mn |
| Sep 30, 2021 | 4.98 Mn |